Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02489656
Other study ID # DUDLUIV1201EC
Secondary ID
Status Recruiting
Phase Phase 4
First received May 18, 2015
Last updated July 1, 2015
Start date September 2013
Est. completion date December 2016

Study information

Verified date May 2015
Source Coloplast A/S
Contact Pascale HS Holliday, CTM
Phone +33 1 40 83 68 58
Email frpho@coloplast.com
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

This study is a prospective, randomized multicenter study conducted in Europe. It is designed to compare two double loop ureteral stents in terms of the quality of life in patients operated on a kidney stone and requiring the placement of a double loop ureteral stent at the end of the operation.


Description:

- The double loop stents are used for both prevention and treatment of ureteral obstruction: They permit the interim internal bypass drainage of urine when obstruction in the ureter especially in cases of lithiasis or after surgical intervention on the upper urinary tract.

- There are many indications for double loop stent placement and population chosen for this study are adult patients with intra-renal calcium calculi of 7-20 mm in diameter for whom the treatment indication is a flexible ureterorenoscopy.

- The aims of the use of a double loop stent are to

- prevent complications (pain, infection) associated with the ureteral obstruction by any residual stone fragments, blood clot or local oedema generated by the intervention.

- preserve the renal function.

- facilitate healing process while limiting the risk of stenosis and probably reduce the rate of readmission after patients' discharge.

- Double loop Stent-related symptoms have a high prevalence and may affect over 80% of patients.

- Assessment tools are important to determine the symptoms intensity and allow for comparisons at different times. The Urinary Stent Symptom Questionnaire (USSQ) is the most adapted tool designed for this purpose.

- An ideal ureteral stent is expected to drain well, to be easy to insert and to be comfortable for the patients. The investigators designed a hydro-coated Silicone JJ stent with additional properties for improving patient's comfort.

- The investigators decided to perform a randomized clinical investigation to evaluate the Coloplast Hydrocoated Silicone JJ in comparison to the Boston Percuflex Plus JJ stent on patients' comfort.


Recruitment information / eligibility

Status Recruiting
Enrollment 140
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Male and female patients

2. Aged > 18 years

3. Unilateral renal non-infection stone for whom the treatment indication is a flexible ureterorenoscopy (multiple kidney stones are acceptable provided that only one side is currently symptomatic)

4. Index stone of 5-25 mm (measured on plain abdomen X-Ray KUB or CT)

5. Without any currently implanted JJ stent

6. Patient agreed to participate to the study and having signed the consent form

7. Able to complete self-rated questionnaires.

Exclusion Criteria:

1. Acute ureteric/nephritic colic (residual pain is acceptable)

2. Any type of chronic pain

3. Large stones > 25 mm

4. Infection renal stone already diagnosed and documented

5. Malformation of urinary tract (e.g. Horseshoe kidney, duplicity or, ureterocele, mega ureter)

6. Diverticulum stone

7. Urogenital tumor

8. Any significant neurological disease or injury impacting sensation

9. JJ stents already implanted

10. Patients with long-term indwelling urethral catheter

11. No indication for JJ insertion (e.g. spontaneous stone passage)

12. Untreated urinary tract infection

13. Ureteral obstruction (stenosis, compression, calculi)

14. Neurogenic bladder

15. Overactive bladder

16. Bladder stone

17. Chronic prostatitis

18. BPH treated (recent initiation of 5 alpha-Reductase Inhibitor or Phytotherapeutic agents)

19. Ongoing Alpha-Blocker or Anticholinergic medication

20. Pregnancy

21. Any event discovered during the endoscopy which is not compatible with the study design and objective

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Double Loop Ureteral stent endoscopic placement.
A JJ stent placement may be indicated at the end of the endourological removal of kidney stones to ensure urine drainage and cicatrisation

Locations

Country Name City State
France Service de Chirurgie Urologique de l'Hôpital Tenon Paris

Sponsors (1)

Lead Sponsor Collaborator
Coloplast A/S

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Other Encrustation of double loop ureteral stents Encrustation of double loop ureteral stents is evaluated by a score of integer values ranging from 0 to 6 after 20 days (JJ stent removal) No
Primary USSQ scale (Ureteral Stent Symptoms Questionnaire) at day 20 No
Secondary Evaluate impact on quality of life via the USSQ questionnaire assessing 5 other scores and adverse event reporting at all visits. Day 2, 7 and 35 No
See also
  Status Clinical Trial Phase
Recruiting NCT05100017 - Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure N/A
Recruiting NCT04559321 - Holmium Vs Trilogy Kidney Stones GUY's 1-2 Phase 3
Completed NCT04332861 - Evaluation of Infection in Obstructing Urolithiasis
Recruiting NCT05578807 - Total Tubeless Percutaneous Nephrolithotomy Without a Ureteral Catheter N/A
Completed NCT03018899 - Paravertebral Block Versus Epidural Anesthesia for Percutaneous Nephrolithotomy N/A
Completed NCT00177086 - Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi Phase 3
Completed NCT03957109 - Influence of Anesthesia Methods on Surgical Outcomes and Renal Function N/A
Completed NCT05082142 - Tranexamic Acid to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP) Phase 4
Completed NCT05911945 - Failed Insertion of Ureteral Access Sheath During Flexible Ureterorenoscopy N/A
Recruiting NCT03599297 - Bilateral Synchronous Simultaneous Stone Surgery N/A
Recruiting NCT05701098 - SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD) N/A
Completed NCT03888144 - Study of Ketorolac Versus Opioid for Pain After Endoscopy Phase 4
Withdrawn NCT04545528 - The Impact of Nutritional Service in the Stone Clinic on the Patient Urine Collection Results
Recruiting NCT05598671 - Percutaneous Nephrolithotomy Without a Ureteral Catheter N/A
Completed NCT05511545 - The Effect of Education Given to Patients on Pre- and Post-operative Anxiety and Preparation for Discharge N/A
Not yet recruiting NCT04606758 - Fluoroscopic Guided vs US-guided Percutaneous Nephrolithotripsy for the Treatment of Stone Disease N/A
Recruiting NCT03855787 - Ureteral Stent Placement After Ureteroscopy for Renal Stones: A Randomized Controlled Trial N/A
Completed NCT04069338 - Comparison of Lithotripsy Urolithiasis Machines N/A
Completed NCT01329042 - Efficacy of Potassium Sodium Hydrogen Citrate Therapy on Renal Stone Recurrence and/or Residual Fragments After Shockwave Lithotripsy and Percutaneous Nephrolithotomy in Calcium Oxalate Urolithiasis Phase 4
Recruiting NCT04069013 - Standard vs Mini-PCNL for the Treatment of Stone Disease N/A